Zeke Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.93M | Buy |
11,916
+927
| +8% | +$150K | 0.13% | 76 |
|
|
2022
Q3 | $1.48M | Sell |
10,989
-18
| -0.2% | -$2.42K | 0.11% | 95 |
|
|
2022
Q2 | $1.69M | Buy |
11,007
+315
| +3% | +$48.3K | 0.11% | 92 |
|
|
2022
Q1 | $1.73M | Buy |
10,692
+9,018
| +539% | +$1.46M | 0.09% | 99 |
|
|
2021
Q4 | $227K | Buy |
+1,674
| New | +$227K | 0.01% | 266 |
|
|
2020
Q2 | – | Sell |
-8,730
| Closed | -$665K | – | 216 |
|
|
2020
Q1 | $665K | Sell |
8,730
-18,004
| -67% | -$1.37M | 0.19% | 69 |
|
|
2019
Q4 | $2.37M | Buy |
26,734
+1,281
| +5% | +$113K | 0.2% | 97 |
|
|
2019
Q3 | $1.93M | Sell |
25,453
-8,929
| -26% | -$676K | 0.17% | 102 |
|
|
2019
Q2 | $2.5M | Sell |
34,382
-914
| -3% | -$66.5K | 0.24% | 85 |
|
|
2019
Q1 | $2.84M | Buy |
35,296
+4,951
| +16% | +$399K | 0.26% | 77 |
|
|
2018
Q4 | $2.8M | Buy |
30,345
+8,260
| +37% | +$761K | 0.27% | 75 |
|
|
2018
Q3 | $2.09M | Buy |
22,085
+410
| +2% | +$38.8K | 0.17% | 91 |
|
|
2018
Q2 | $2.01M | Sell |
21,675
-12,540
| -37% | -$1.16M | 0.19% | 92 |
|
|
2018
Q1 | $3.24M | Buy |
34,215
+3,649
| +12% | +$345K | 0.3% | 62 |
|
|
2017
Q4 | $2.96M | Buy |
30,566
+5,073
| +20% | +$491K | 0.31% | 58 |
|
|
2017
Q3 | $2.27M | Buy |
25,493
+11,626
| +84% | +$1.03M | 0.31% | 57 |
|
|
2017
Q2 | $1.01M | Buy |
13,867
+2,883
| +26% | +$209K | 0.19% | 66 |
|
|
2017
Q1 | $716K | Buy |
10,984
+681
| +7% | +$44.4K | 0.15% | 77 |
|
|
2016
Q4 | $645K | Buy |
10,303
+4,529
| +78% | +$284K | 0.17% | 68 |
|
|
2016
Q3 | $353K | Buy |
+5,774
| New | +$353K | 0.16% | 49 |
|